China Digest: SmartX nets $29m; Hillhouse leads funding in Brosmed

SmartX has garnered 200 million yuan ($29 million) in its Series B+ and C rounds from Vertex Ventures China, Tianjin Venture Capital and HUA Capital while Brosmed Medical has secured ‘tens of millions of US dollars’ in its Series C funding led by Hillhouse Capital.